Home/Filings/4/0001493152-23-001212
4//SEC Filing

Osorio Benedict 4

Accession 0001493152-23-001212

CIK 0001695357other

Filed

Jan 10, 7:00 PM ET

Accepted

Jan 11, 9:14 PM ET

Size

5.7 KB

Accession

0001493152-23-001212

Insider Transaction Report

Form 4
Period: 2023-01-10
Osorio Benedict
Chief Quality Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-01-10+187,000187,000 total
    Exercise: $8.93Exp: 2033-01-10Common Stock, par value $0.0001 (187,000 underlying)
Footnotes (2)
  • [F1]The options will vest and become exercisable as to 25% on the one-year anniversary of the grant date (January 10, 2024) and the remaining 75% will vest and become exercisable monthly over 36 months such that the options are fully vested and exercisable on the four-year anniversary of the grant date (January 10, 2027).
  • [F2]The securities were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan.

Documents

1 file

Issuer

Provention Bio, Inc.

CIK 0001695357

Entity typeother

Related Parties

1
  • filerCIK 0001732730

Filing Metadata

Form type
4
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 9:14 PM ET
Size
5.7 KB